STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Holding DE:SBS?
Track your performance easily

STRATEC Biomedical (SBS) Cash flow

3 Followers

STRATEC Biomedical Cash Flow

DE:SBS's free cash flow for Q4 2022 was €-18.88M. For the 2022 fiscal year, DE:SBS's free cash flow was decreased by €-51.98M and operating cash flow was €-12.01M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
€ 10.28M€ 10.28M€ 63.47M€ 31.85M€ 21.26M€ 11.95M
Investing Cash Flow
€ -19.00M€ -19.00M€ -20.13M€ -21.84M€ -27.72M€ -10.79M
Financing Cash Flow
€ -14.11M€ -14.11M€ -34.33M€ 5.22M€ 5.45M€ -927.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
€ 155.44M€ 22.67M€ 47.18M€ 37.56M€ 22.71M€ 24.09M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
€ 1.50M€ 1.74M€ 1.26M€ 2.80M€ 2.01M€ 1.58M
Issuance Of Debt
€ 2.85M--€ 32.00M€ 23.00M€ 9.00M
Repayment Of Debt
€ -4.84M--€ -19.48M€ -9.75M€ -1.97M
Free Cash Flow
€ -8.74M€ -8.74M€ 43.24M€ 6.27M€ -5.58M€ -7.49M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

STRATEC Biomedical Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis